HDL-increasing effect of cyclofenil.
Nineteen patients with low levels of HDL as measured by APO-AI have been treated with cyclofenil (a non-steroid stilboestrol isomer with very low oestrogenic effects) as the only form of therapy. The therapy elicited a highly significant rise of about 15% in HDL levels. A slight increase in transaminases occurred in 6 patients but was reversible without terminating therapy.
D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease / Q000517:prevention & control; D003408:Cresols / Q000494:pharmacology*; D003506:Cyclofenil / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D008297:Male; D008875:Middle Aged
D003408:Cresols; D008075:Lipoproteins, HDL; D002784:Cholesterol; D003506:Cyclofenil